Cargando…

Imaging modalities in synchronous oligometastatic prostate cancer

PURPOSE: Along with a number of other malignancies, the term “oligometastatic” prostate cancer has recently emerged. It represents an attempt to define a subtype of cancer with a limited metastatic load that might perform more favorably than a distinctly disseminated disease, or even one that may be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Futterer, Jurgen J., Surcel, Cristian, van den Bergh, Roderick, Borgmann, Hendrik, Briganti, Alberto, Gandaglia, Giorgio, Kretschmer, Alexander, Ost, Piet, Sooriakumaran, Prasanna, Tilki, Derya, Valerio, Massimo, Ploussard, Guillaume, De Visschere, Pieter J. L., Tsaur, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868105/ https://www.ncbi.nlm.nih.gov/pubmed/30069582 http://dx.doi.org/10.1007/s00345-018-2416-2

Ejemplares similares

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
por: De Visschere, Pieter J. L., et al.
Publicado: (2016)

Molecular Mechanisms Related with Oligometastatic Prostate Cancer—Is It Just a Matter of Numbers?
por: Surcel, Cristian, et al.
Publicado: (2022)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Radical Prostatectomy: Sequelae in the Course of Time
por: Kesch, Claudia, et al.
Publicado: (2021)

Primary Tumour Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Ting, Francis, et al.
Publicado: (2022)

Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2020)

Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
por: Zattoni, Fabio, et al.
Publicado: (2021)

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer
por: Tsaur, Igor, et al.
Publicado: (2021)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
por: Mercier, Carole, et al.
Publicado: (2022)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

The current role of precision surgery in oligometastatic prostate cancer
por: von Deimling, M., et al.
Publicado: (2022)

Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology
por: Jadvar, Hossein
Publicado: (2018)

MRI as a screening tool for prostate cancer: current evidence and future challenges
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study
por: Zattoni, Fabio, et al.
Publicado: (2021)

Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic
por: Dotzauer, Robert, et al.
Publicado: (2020)

Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives
por: Kretschmer, Alexander, et al.
Publicado: (2021)

How to deal with steroids use in the management of metastatic prostate cancer during pandemic
por: Baboudjian, Michael, et al.
Publicado: (2020)

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
por: Preisser, Felix, et al.
Publicado: (2021)

The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions
por: Zattoni, Fabio, et al.
Publicado: (2023)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
por: Heidegger, Isabel, et al.
Publicado: (2022)

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
por: Jones, Gregory D., et al.
Publicado: (2021)

Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer
por: Huynh, Linda My, et al.
Publicado: (2022)

Diagnosing cardiac disease during pregnancy: imaging modalities
por: Ntusi, Ntobeko AB, et al.
Publicado: (2016)

Laser-assisted Hair Regrowth: Fractional Laser Modalities for the Treatment of Androgenic Alopecia
por: Dabek, Robert J., et al.
Publicado: (2019)

Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-Up
por: De Visschere, Pieter, et al.
Publicado: (2016)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Safety and feasibility of same-day discharge laparoscopic radical prostatectomy: a systematic review
por: Saouli, Amine, et al.
Publicado: (2022)

Lungenmetastasen – Onkologische Bedeutung und Therapie
por: Krämer, Sebastian, et al.
Publicado: (2023)

Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
por: Boni, Andrea, et al.
Publicado: (2018)

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma
por: Shi, Zhenguo, et al.
Publicado: (2022)

The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer
por: Zhang, Zhenshan, et al.
Publicado: (2023)

Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
por: Mahjoub, Samy, et al.
Publicado: (2021)

Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
por: Rogowski, Paul, et al.
Publicado: (2021)

High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
por: Fütterer, Jurgen J., et al.
Publicado: (2011)

Should patients undergo ascending aortic replacement with concomitant cardiac surgery?
por: Yalcin, Mihriban, et al.
Publicado: (2016)

Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study
por: Shao, Yi, et al.
Publicado: (2020)

Renal angiomyolipoma presenting with massive retroperitoneal haemorrhage due to deranged clotting factors: a case report
por: Wright, Timothy, et al.
Publicado: (2008)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
por: Decaestecker, Karel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m9f2bjiumt9dt1kh8mku5bj1d6